Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
| العنوان: | Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease |
|---|---|
| المؤلفون: | Huajing You, Tengteng Wu, Gang Du, Yue Huang, Yixuan Zeng, Lishan Lin, Dingbang Chen, Chao Wu, Xunhua Li, Jean-marc Burgunder, Zhong Pei |
| المصدر: | Frontiers in Neurology Frontiers in Neurology, Vol 12 (2021) You, Huajing; Wu, Tengteng; Du, Gang; Huang, Yue; Zeng, Yixuan; Lin, Lishan; Chen, Dingbang; Wu, Chao; Li, Xunhua; Burgunder, Jean-Marc; Pei, Zhong (2021). Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease. Frontiers in neurology, 12, p. 779890. Frontiers Media S.A. 10.3389/fneur.2021.779890 <http://dx.doi.org/10.3389/fneur.2021.779890Test> |
| بيانات النشر: | Frontiers Media S.A., 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, Neurofilament light, 610 Medicine & health, Disease, Gastroenterology, Huntington's disease, Internal medicine, medicine, Clinical severity, RC346-429, Motor score, Original Research, Word reading, neurofilament light protein, Glial fibrillary acidic protein, biology, business.industry, medicine.disease, Neurology, nervous system, glial fibrillary acidic protein, clinical severity, biology.protein, Biomarker (medicine), biomarker, Neurology (clinical), Neurology. Diseases of the nervous system, business |
| الوصف: | Objective: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. Neurofilament light protein (NfL) is correlated with clinical severity of HD but relative data are the lack in the Chinese population. Reactive astrocytes are related to HD pathology, which predicts their potential to be a biomarker in HD progression. Our aim was to discuss the role of blood glial fibrillary acidic protein (GFAP) to evaluate clinical severity in patients with HD.Methods: Fifty-seven HD mutation carriers (15 premanifest HD, preHD, and 42 manifest HD) and 26 healthy controls were recruited. Demographic data and clinical severity assessed with the internationally Unified Huntington's Disease Rating Scale (UHDRS) were retrospectively analyzed. Plasma NfL and GFAP were quantified with an ultra-sensitive single-molecule (Simoa, Norcross, GA, USA) technology. We explored their consistency and their correlation with clinical severity.Results: Compared with healthy controls, plasma NfL (p < 0.0001) and GFAP (p < 0.001) were increased in Chinese HD mutation carriers, and they were linearly correlated with each other (r = 0.612, p < 0.001). They were also significantly correlated with disease burden, Total Motor Score (TMS) and Total Functional Capacity (TFC). The scores of Stroop word reading, symbol digit modalities tests, and short version of the Problem Behaviors Assessments (PBAs) for HD were correlated with plasma NfL but not GFAP. Compared with healthy controls, plasma NfL has been increased since stage 1 but plasma GFAP began to increase statistically in stage 2.Conclusions: Plasma GFAP was correlated with plasma NfL, disease burden, TMS, and TFC in HD mutation carriers. Plasma GFAP may have potential to be a sensitive biomarker for evaluating HD progression. |
| وصف الملف: | application/pdf |
| DOI: | 10.48350/163639 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b4432e699acac04c598c74cc483beaTest |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....48b4432e699acac04c598c74cc483bea |
| قاعدة البيانات: | OpenAIRE |
| DOI: | 10.48350/163639 |
|---|